📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Genetic medicines for CF: Hype versus reality. (2016)

First Author: Alton EW

Attributed to: Development of a novel, potent, safe, long-lasting lentivirus-based gene therapy for cystic fibrosis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/ppul.23543

PubMed Identifier: 27662105

Publication URI: http://europepmc.org/abstract/MED/27662105

Type: Journal Article/Review

Volume: 51

Parent Publication: Pediatric pulmonology

Issue: S44

ISSN: 1099-0496